The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Global GP681 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global GP681 market size is expected to reach $ 195 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032). GP681 is a novel oral antiviral drug targeting i...
June 2026
92 pages
Global IMP4279 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global IMP4279 market size is expected to reach $ 50.90 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032). IMP4279 is a novel DNA damage response pathw...
June 2026
93 pages
Global SHR0302 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global SHR0302 market size is expected to reach $ 1234 million by 2032, rising at a market growth of 16.9% CAGR during the forecast period (2026-2032). SHR0302 (generic name: Ivarmacitinib) is a h...
June 2026
88 pages
Mexico Medical Cannabis Market Size, Share, Trends and Forecast by Species, Derivatives, Application, Route of Administration, End Use, and Region, 2026-2034
US$ 2,999.00
The Mexico medical cannabis market size reached USD 595.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,105.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.91...
June 2026
122 pages
Mexico Pain Management Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Mexico pain management drugs market size reached USD 1,096.6 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,353.5 Million by 2034 , exhibiting a growth rate (CAGR...
June 2026
122 pages
Mexico Active Pharmaceutical Ingredients Market Size, Share, Trends and Forecast by Drug Type, Manufacturer Type, Synthesis Type, Therapeutic Application, and Region, 2026-2034
US$ 2,999.00
The Mexico active pharmaceutical ingredients market size was valued at USD 3,847.41 Million in 2025 and is projected to reach USD 5,601.68 Million by 2034, growing at a compound annual growth rate of...
June 2026
118 pages
Fucosidosis Treatment Market - 2026-2033
US$ 3,400.00
Fucosidosis Treatment Market reached USD 185.2 million in 2025 and is expected to reach USD 356.3 million by 2033, growing with a CAGR of 8.30% during the forecast period 2026-2033. The Fucosidosis Tr...
May 2026
47 pages
Hemangioma Treatment Market - 2026-2033
US$ 3,400.00
Hemangioma Treatment Market reached USD 318.3 million in 2025 and is expected to reach USD 427.9 million by 2033, growing with a CAGR of 3.80% during the forecast period 2026-2033. The Hemangioma Trea...
May 2026
46 pages
Homocystinuria Market - 2026-2033
US$ 3,400.00
Homocystinuria Market reached US$ 412.62 million in 2025 and is expected to reach US$ 689.42 million by 2033, growing with a CAGR of 6.20% during the forecast period 2026-2033. The Homocystinuria Mark...
May 2026
40 pages
Primary Biliary Cholangitis Treatment Market - 2026-2033
US$ 3,400.00
Primary Biliary Cholangitis Treatment Market reached US$ 1.43 billion in 2025 and is expected to reach US$ 2.72 billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The...
May 2026
63 pages
Andersen-Tawil Syndrome Market - 2026-2033
US$ 3,400.00
Andersen-Tawil Syndrome Market reached USD 2.44 million in 2025 and is expected to reach USD 4.19 million by 2033, growing with a CAGR of 7.00% during the forecast period 2026-2033. The Andersen-Tawil...
May 2026
49 pages
Hyperuricemia Market - 2026-2033
US$ 3,400.00
Hyperuricemia Market reached US$ 1.89 billion in 2025 and is expected to reach US$ 4.01 billion by 2033, growing with a CAGR of 5.40% during the forecast period 2026-2033. The Hyperuricemia Market eme...
May 2026
39 pages
Nasal Polyps Treatment Market - 2026-2033
US$ 3,400.00
Nasal Polyps Treatment Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Nasal Polyps Treatment Market emerges as a key focus in DataM Intelligence latest in-depth ana...
May 2026
48 pages
Splenomegaly Therapeutics Market - 2026-2032
US$ 3,400.00
Splenomegaly Therapeutics Marketis is growing with a CAGR of 3.00% during the forecast period 2026-2035. The Splenomegaly Therapeutics Market emerges as a key focus in DataM Intelligence latest in-dep...
May 2026
51 pages
Mastocytosis Treatment Market - 2026-2033
US$ 3,400.00
The Mastocytosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
May 2026
48 pages
Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutics Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Venom Based Drugs Market will grow from USD 1.19 Billion in 2025 to USD 1.72 Billion by 2031 at a 6.33% CAGR. The global market for venom-based drugs centers on therapeutic agents derived f...
May 2026
180 pages
Penicillin Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Bulk, Dosage), By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others), By Route of Administration (Oral, Intramuscular, Intravenous), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The global penicillin market is projected to expand from USD 10.43 Billion in 2025 to USD 13.21 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 4.02%. Penicillin, a group of bet...
May 2026
188 pages
Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Buds/Marijuana Flower, Cannabis Extracts), By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others), By Distribution Channel (B2B, B2C), By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others), By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Medical Cannabis Market is anticipated to experience substantial growth, expanding from USD 28.81 Billion in 2025 to USD 90.82 Billion by 2031 at a CAGR of 21.09%. This market involves the...
May 2026
180 pages
Muscle Relaxant Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global muscle relaxant drugs market is projected to expand from USD 4.15 Billion in 2025 to USD 5.38 Billion by 2031, exhibiting a 4.42% Compound Annual Growth Rate. These pharmaceutical agents ar...
May 2026
182 pages
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Haemophilia Treatment Market is projected to expand from USD 12.03 Billion in 2025 to USD 16.82 Billion by 2031, registering a CAGR of 5.75%. Treatment methodologies include replacement the...
May 2026
180 pages
Addison’s Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency, Tertiary Adrenal Insufficiency), By Drug Class (Oral Corticosteroid, Corticosteroid Injections, Sodium Intake), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Addison's Disease Market is anticipated to grow from USD 546.23 Million in 2025 to USD 809.68 Million by 2031, achieving a Compound Annual Growth Rate (CAGR) of 6.78%. This market primarily...
May 2026
180 pages
Andersen-Tawil Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Type 1, Type 2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Andersen-Tawil Syndrome is projected to expand from USD 2.78 billion in 2025 to USD 4.25 billion by 2031, demonstrating a compound annual growth rate of 7.33%. This market primar...
May 2026
182 pages
Ankylosing Spondylitis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia), By End Use (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Ankylosing Spondylitis therapeutics is projected to expand significantly, rising from USD 7.88 Billion in 2025 to USD 11.27 Billion by 2031, at a Compound Annual Growth Rate of 6...
May 2026
182 pages
